ýҕl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ýҕl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Apr 3 2026

Full Issue

Hoping To Dodge Trump's Tariffs, Small Drugmakers Mull Pricing Deals

Smaller pharmaceutical companies that don't negotiate deals to lower drug costs could see the administration's latest tariffs — set at 100% — go into effect in 180 days.

The Trump administration is negotiating new drug-pricing deals, now with smaller companies, according to three people with knowledge of the meetings, including a White House official. (Payne, 4/2)

More on the high cost of health care —

Sens. Bernie Sanders (I-Vt.) and Ron Wyden (D-Ore.) are calling on Republican committee leaders to hold hearings with the chief executives of top health insurers in the U.S. as they “continue to get rich” during a time when health care access and affordability are of top concern. Sanders and Wyden wrote to Sens. Bill Cassidy (R-La.) and Mike Crapo (R-Idaho), chairs of the Senate Health and Finance committees respectively, asking that they bring in the health care CEOs to testify. (Choi, 4/2)

As Democrats vie to take control of Congress in the midterms this fall, their main message on health care policy is fairly straightforward: Undo Republicans’ Medicaid cuts and restore the health care subsidies that lapsed at the end of last year. But some analysts and lawmakers say momentum is growing for a bigger health care push in 2028. (DeGroot, 4/2)

ýҕl Health News: ýҕl Health News’ ‘What The Health?’: GOP Mulls More Health Cuts

Recent polling finds that health costs are a top worry for much of the American public, while Republicans in Congress are considering still more cuts to federal health spending on programs such as Medicaid and the Affordable Care Act. Meanwhile, the Supreme Court ruled that Colorado cannot ban mental health professionals from using “conversion therapy” to treat LGBTQ+ minors, a decision that’s likely to affect other states with similar laws. (Rovner, 4/2)

ýҕl Health News: Tax Time Brings Surprises For Some Who Receive ACA Subsidies

Tax time can come with big surprises for some people who have Affordable Care Act coverage, including owing money back to the government for premium subsidies received during the previous year. More changes lie ahead that make it important for those getting subsidies in 2026 to track their income and take steps to protect against that kind of financial hit. (Appleby and Jones, 4/3)

Cancer is becoming increasingly common among young people, with cases slowly and steadily rising every year for the past decade. And what type of insurance adolescents and young adults have affects at what stage of cancer they’re diagnosed and how long they survive. (Winegar, Martin and Liu, 4/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • ýҕl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF